‘Unadulterated rubbish’: Scientists on Ayush ministry’s COVID-19 trials
The ministry claims traditional medicines help in speedy recovery from COVID-19 and its prevention even as scientists question the clinical trials’ methodology.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
$99 for one year
More in Chaos
You may also like
How Bewakoof, once a trendsetter, fell out of favour with young people
Indian youngsters are experimenting with newer D2C brands like never before. Bewakoof’s early success and its 2022 acquisition by retail giant Aditya Birla Fashion should have given it the edge, but the company has been left behind.
Why Nifty 50’s profit is the lowest since COVID-19 pandemic
The earnings of India’s oil refiners and other Nifty 50 companies have taken a hit. But IPO premiums suggest that investors seem unfazed.
Can India finally rein in misleading claims in advertisements?
The Supreme Court has mandated all advertisers to submit self-declarations certifying that their ads had no bogus claims. Easier said than implemented.
